These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35370807)

  • 1. The Lack of Dopamine Transporter Is Associated With Conditional Associative Learning Impairments and Striatal Proteomic Changes.
    Savchenko A; Müller C; Lubec J; Leo D; Korz V; Afjehi-Sadat L; Malikovic J; Sialana FJ; Lubec G; Sukhanov I
    Front Psychiatry; 2022; 13():799433. PubMed ID: 35370807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats.
    Leo D; Sukhanov I; Zoratto F; Illiano P; Caffino L; Sanna F; Messa G; Emanuele M; Esposito A; Dorofeikova M; Budygin EA; Mus L; Efimova EV; Niello M; Espinoza S; Sotnikova TD; Hoener MC; Laviola G; Fumagalli F; Adriani W; Gainetdinov RR
    J Neurosci; 2018 Feb; 38(8):1959-1972. PubMed ID: 29348190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the PDZ domain-binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis, and reward motivation.
    Sørensen G; Rickhag M; Leo D; Lycas MD; Ridderstrøm PH; Weikop P; Lilja JH; Rifes P; Herborg F; Woldbye D; Wörtwein G; Gainetdinov RR; Fink-Jensen A; Gether U
    J Biol Chem; 2021 Dec; 297(6):101361. PubMed ID: 34756883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Region-Specific Trafficking of the Dopamine Transporter.
    Block ER; Nuttle J; Balcita-Pedicino JJ; Caltagarone J; Watkins SC; Sesack SR; Sorkin A
    J Neurosci; 2015 Sep; 35(37):12845-58. PubMed ID: 26377471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Dopamine Reduces In Vivo [(123)I]FP-CIT Binding to Striatal Dopamine Transporter: Correlation with Behavioral Changes and Evidence for Pavlovian Conditioned Dopamine Response.
    de Souza Silva MA; Mattern C; Decheva C; Huston JP; Sadile AG; Beu M; Müller HW; Nikolaus S
    Front Behav Neurosci; 2016; 10():80. PubMed ID: 27148001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locomotor hyperactivity in 14-3-3ζ KO mice is associated with dopamine transporter dysfunction.
    Ramshaw H; Xu X; Jaehne EJ; McCarthy P; Greenberg Z; Saleh E; McClure B; Woodcock J; Kabbara S; Wiszniak S; Wang TY; Parish C; van den Buuse M; Baune BT; Lopez A; Schwarz Q
    Transl Psychiatry; 2013 Dec; 3(12):e327. PubMed ID: 24301645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake.
    Chotibut T; Apple DM; Jefferis R; Salvatore MF
    PLoS One; 2012; 7(12):e52322. PubMed ID: 23300642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice.
    Ji J; Dluzen DE
    J Neural Transm (Vienna); 2008 Jun; 115(6):809-17. PubMed ID: 18197357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Instrumental learning in hyperdopaminergic mice.
    Yin HH; Zhuang X; Balleine BW
    Neurobiol Learn Mem; 2006 May; 85(3):283-8. PubMed ID: 16423542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter function fluctuates across sleep/wake state: potential impact for addiction.
    Alonso IP; Pino JA; Kortagere S; Torres GE; España RA
    Neuropsychopharmacology; 2021 Mar; 46(4):699-708. PubMed ID: 33032296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual variation in incentive salience attribution and accumbens dopamine transporter expression and function.
    Singer BF; Guptaroy B; Austin CJ; Wohl I; Lovic V; Seiler JL; Vaughan RA; Gnegy ME; Robinson TE; Aragona BJ
    Eur J Neurosci; 2016 Mar; 43(5):662-70. PubMed ID: 26613374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease.
    Giangrasso DM; Furlong TM; Keefe KA
    Neurobiol Dis; 2020 Feb; 134():104673. PubMed ID: 31734455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the sonic hedgehog receptor smoothened on the survival and function of dopaminergic neurons.
    Zhou X; Pace J; Filichia E; Lv T; Davis B; Hoffer B; Selman W; Luo Y
    Exp Neurol; 2016 Sep; 283(Pt A):235-45. PubMed ID: 27317298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze.
    Kurzina NP; Aristova IY; Volnova AB; Gainetdinov RR
    Behav Brain Res; 2020 Jul; 390():112642. PubMed ID: 32428629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.
    Salvatore MF; Calipari ES; Jones SR
    ACS Chem Neurosci; 2016 Jul; 7(7):941-51. PubMed ID: 27124386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
    J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Dopamine Synaptic Markers in Postmortem Brain of Obese Subjects.
    Wu C; Garamszegi SP; Xie X; Mash DC
    Front Hum Neurosci; 2017; 11():386. PubMed ID: 28824395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking.
    Ikemoto S; Panksepp J
    Brain Res Brain Res Rev; 1999 Dec; 31(1):6-41. PubMed ID: 10611493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related changes in nigrostriatal dopaminergic function in heterozygous mutant dopamine transporter knock-out mice.
    Dluzen DE; Ji J; McDermott JL
    Neurosci Lett; 2010 May; 476(2):66-9. PubMed ID: 20382201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury.
    Wagner AK; Drewencki LL; Chen X; Santos FR; Khan AS; Harun R; Torres GE; Michael AC; Dixon CE
    J Neurochem; 2009 Feb; 108(4):986-97. PubMed ID: 19077052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.